|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 4.86 CNY | +1.89% |
|
+3.40% | +0.41% |
On February 14, 2022, NanJing Pharmaceutical Company Limited closed the transaction. The company has issued 250,753,768 shares for gross proceeds of CNY 997,999,996.64. The company has incurred expenses of CNY 10,525,471.70 and received net proceeds of CNY 987,474,524.94.
Post the closing, the total number of shares held by Nanjing XinGong Investment Group Co., Ltd will increase from 327,453,518 shares to 578,207,286 shares, and its stake will increase from 30.95% to 44.18%.
| 1st Jan change | Capi. | |
|---|---|---|
| +0.41% | 880M | |
| +14.35% | 69.79B | |
| +7.11% | 8.2B | |
| -20.55% | 7.96B | |
| -5.04% | 7.91B | |
| +2.32% | 4.69B | |
| +17.12% | 4.32B | |
| -1.24% | 3.99B | |
| -3.78% | 3.81B | |
| +21.42% | 3.62B |
NANJING PHARMACEUTICAL COMPANY LIMITED 
